ClinConnect ClinConnect Logo
Search / Trial NCT00217165

Taurine as an Anti-Manic Agent: A Double-Blind, Placebo-Controlled Study

Launched by MCLEAN HOSPITAL · Sep 15, 2005

Trial Information

Current as of June 24, 2025

Completed

Keywords

Bipolar Mania Depression Taurine Alternative

ClinConnect Summary

Taurine is an amino acid that has some actions similar to mood stabilizers. Taurine is widely sold as a component of over-the-counter mood enhancing agents. However, controlled studies examining the mood effects of taurine are limited. An initial study in this laboratory looked at taurine's mood effects in individuals with bipolar disorder. This follow-up study is designed to further examine taurine's effects on manic symptoms. Subjects in the current follow-up study will add taurine or placebo to their current treatment regimen. Both depressive and manic symptoms will be tracked for three ...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • bipolar disorder, type I bipolar disorder, type II mania hypomania mixed manic symptoms
  • Exclusion Criteria:
  • significant medical or psychiatric co-morbidity pregnancy or planning pregnancy current substance abuse or dependence
  • -

About Mclean Hospital

McLean Hospital, a leading psychiatric affiliate of Harvard Medical School, is dedicated to advancing mental health care through innovative research and clinical trials. Renowned for its commitment to scientific excellence, McLean harnesses a multidisciplinary approach to address a wide range of psychiatric disorders, including depression, anxiety, and schizophrenia. With state-of-the-art facilities and a team of expert clinicians and researchers, the hospital aims to develop effective treatment strategies and improve patient outcomes. Its robust clinical trial program fosters collaboration and contributes to the broader understanding of mental health, ultimately enhancing therapeutic options for individuals in need.

Locations

Belmont, Massachusetts, United States

Patients applied

0 patients applied

Trial Officials

Beth L Murphy, MD, PhD

Principal Investigator

Mclean Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials